Doximity Inc (NASDAQ:DOCS) stock is trading higher on Friday after the company reported third-quarter fiscal 2025 results that beat analysts’ expectations and upbeat guidance.
Doximity reported adjusted EPS of 45 cents, up from 29 cents a year ago and beating the consensus of 34 cents.
Sales increased 25% year-over-year to $168.6 million, beating the consensus of $152.82 million and management guidance of $152 million to $153 million.
Doximity offers a digital platform for U.S. medical professionals
“We’re proud to deliver another quarter of record engagement in Q3, with over 610,000 unique providers using our clinical workflow tools,” Doximity CEO Jeff Tangney said in a statement.
“Our AI tools grew the fastest last quarter, up 60% over the prior quarter, while our newsfeed surpassed more than one million unique providers.”
The company reported an adjusted EBITDA of $102.0 million, up 39% year over year, better than the management forecast of $83 million to $84 million. Net income jumped 57% to $75.2 million.
Guidance: For its fiscal fourth quarter, Doximity said it expects revenue of $132.5 million and $133.5 million, compared with analysts’ estimates of $123.84 million.
The company also raised its 2025 revenue guidance to $564.6 million—$565.6 million, up from the prior outlook of $535 million—$540 million and versus the consensus of $539.98 million.
Adjusted EBITDA is expected to be between $306.6 million and $307.6 million compared to prior guidance of $274 million to $279 million.
Analyst Reaction:
Price Action: DOCS stock is up 37% at $79.80 at last check Friday.
Read Next:
Photo: courtesy of Doximity
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。